Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2014

01-11-2014 | Original Article

High-Definition White-Light (HDWL) Colonoscopy and Higher Adenoma Detection Rate and the Potential for Paradoxical Over Surveillance

Authors: Victoria Gómez, Ronald G. Racho, Michael G. Heckman, Nancy N. Diehl, Michael B. Wallace

Published in: Digestive Diseases and Sciences | Issue 11/2014

Login to get access

Abstract

Background

Patients undergoing high-definition white-light colonoscopy by a high adenoma detector may have a lower risk of interval adenoma detection on follow-up colonoscopy and may require less frequent follow-up but may paradoxically be assigned to more frequent surveillance when more adenomas are detected.

Aims

To evaluate whether high-definition white-light colonoscopy (vs. standard-definition white-light colonoscopy) and endoscopist adenoma detection rate (ADR) at index colonoscopy are associated with increased likelihood of adenomas at follow-up.

Methods

Longitudinal follow-up of prior cross-section cohort study of patients who underwent colonoscopy at baseline with at least one detected adenoma was included. Associations of type of white-light at index colonoscopy and the ADR of the endoscopist at index colonoscopy (high vs. low adenoma detector) were evaluated with various adenoma and polyp detection endpoints. Eighteen endoscopists were classified as high and low adenoma detectors based on the median ADR of 0.255.

Results

There were no significant differences in subsequent interval adenoma or polyp detection endpoints with regard to whether baseline exam was performed with high-definition white-light or standard-definition white-light colonoscopy nor between high and low ADR after adjusting for multiple testing (P ≤ 0.0029 considered significant). Prior to multiple testing adjustment, there was a significantly lower detection rate of hyperplastic polyps in the left colon (24 vs. 35 %, OR: 0.56, P = 0.033) at follow-up colonoscopy when baseline exam was performed with high-definition white-light index colonoscopy.

Conclusions

The results of this study do not support adjusting colonoscopy surveillance guidelines based on type of colonoscopy performed or the endoscopist’s ADR.
Literature
1.
2.
go back to reference Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedCrossRefPubMedCentral Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–696.PubMedCrossRefPubMedCentral
3.
go back to reference Rex DK, Johnson DA, Anderson JC, et al. American college of gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMedCrossRef Rex DK, Johnson DA, Anderson JC, et al. American college of gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol. 2009;104:739–750.PubMedCrossRef
4.
go back to reference Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873–885.PubMed Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2006;101:873–885.PubMed
5.
go back to reference Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol. 2006;101:2866–2877.PubMedCrossRef Rex DK. Maximizing detection of adenomas and cancers during colonoscopy. Am J Gastroenterol. 2006;101:2866–2877.PubMedCrossRef
6.
go back to reference Qumseya BJ, Wallace MB. Advanced colorectal polyp detection techniques. Curr Gastroenterol Rep. 2012;14:414–420.PubMedCrossRef Qumseya BJ, Wallace MB. Advanced colorectal polyp detection techniques. Curr Gastroenterol Rep. 2012;14:414–420.PubMedCrossRef
7.
go back to reference van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–350.PubMedCrossRef van Rijn JC, Reitsma JB, Stoker J, et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–350.PubMedCrossRef
8.
go back to reference Buchner AM, Shahid MW, Heckman MG, et al. High-definition colonoscopy detects colorectal polyps at a higher rate than standard white-light colonoscopy. Clin Gastroenterol Hepatol. 2010;8:364–370.PubMedCrossRef Buchner AM, Shahid MW, Heckman MG, et al. High-definition colonoscopy detects colorectal polyps at a higher rate than standard white-light colonoscopy. Clin Gastroenterol Hepatol. 2010;8:364–370.PubMedCrossRef
9.
go back to reference Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the us multi-society task force on colorectal cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRef Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the us multi-society task force on colorectal cancer. Gastroenterology. 2012;143:844–857.PubMedCrossRef
10.
go back to reference Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795–1803.PubMedCrossRef Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;362:1795–1803.PubMedCrossRef
11.
go back to reference Rogal SS, Pinsky PF, Schoen RE. Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol. 2013;11:73–78.PubMedCrossRefPubMedCentral Rogal SS, Pinsky PF, Schoen RE. Relationship between detection of adenomas by flexible sigmoidoscopy and interval distal colorectal cancer. Clin Gastroenterol Hepatol. 2013;11:73–78.PubMedCrossRefPubMedCentral
12.
go back to reference Corley DAJ, Christopher D, Marks AR, et al. Physician adenoma detection rate variability and subsequent colorectal cancer risk following a negative colonoscopy. Gastroenterology. 2013;144:S2–S3.CrossRef Corley DAJ, Christopher D, Marks AR, et al. Physician adenoma detection rate variability and subsequent colorectal cancer risk following a negative colonoscopy. Gastroenterology. 2013;144:S2–S3.CrossRef
13.
14.
go back to reference Lebwohl B, Kastrinos F, Glick M, et al. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc. 2011;73:1207–1214.PubMedCrossRefPubMedCentral Lebwohl B, Kastrinos F, Glick M, et al. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc. 2011;73:1207–1214.PubMedCrossRefPubMedCentral
15.
go back to reference Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9:42–46.PubMedCrossRef Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9:42–46.PubMedCrossRef
Metadata
Title
High-Definition White-Light (HDWL) Colonoscopy and Higher Adenoma Detection Rate and the Potential for Paradoxical Over Surveillance
Authors
Victoria Gómez
Ronald G. Racho
Michael G. Heckman
Nancy N. Diehl
Michael B. Wallace
Publication date
01-11-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3253-9

Other articles of this Issue 11/2014

Digestive Diseases and Sciences 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine